Diagnostic Performance of a Multiplex Circulating Tumor DNA Assay for Lung Cancer Detection.
Lung cancer remains the leading cause of cancer-related death worldwide, largely due to late-stage diagnosis. Although low-dose computed tomography (LDCT) screening can reduce mortality, it is limited by high false-positive rates, radiation exposure, and low adherence.
Lung cancer remains the leading cause of cancer-related death worldwide, largely due to late-stage diagnosis. Although low-dose computed tomography (LDCT) screening can reduce mortality, it is limited by high false-positive rates, radiation exposure, and low adherence.
What the study was
- Study design
- Cohort/Observational Study
- Category
- Early Detection
- Maturity
- Validated
- Journal
- J Mol Diagn
Why it surfaced
Matched watchlist topic 'Early cancer detection'. Study design: Cohort/Observational Study. Score: 8/10 (N:3, R:3, D:1, P:1).
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.